跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
醫學科技學院
臺北醫學大學
電話
+886-2-27361661#7601
電子郵件
[email protected]
網站
http://comst.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(105)
專案
(1463)
研究成果
(8397)
資料集
(386)
指紋
查看啟用 醫學科技學院 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
9%
Alternative Complement Pathway C3 C5 Convertase
13%
Androgen
7%
Anti-Inflammatory Drug
10%
Anticarcinogen
18%
Anticoagulant Agent
6%
Antioxidant
16%
Antiplatelet
13%
Antitumor Activity
9%
Asthma
7%
Biological Marker
13%
Brain Ischemia
15%
Breast Cancer
29%
Calcium Ion
7%
Cancer Growth
15%
Cancer Growth Factor
7%
Carcinogenesis
22%
Cardiovascular Disease
11%
Caspase
7%
Caspase 3
13%
Cell Viability
9%
Cerebrovascular Accident
23%
Chemotherapy Regimens
14%
Chronic Kidney Failure
19%
Chronic Obstructive Lung Disease
14%
Cisplatin
11%
Clinical Trial
8%
Cohort Study
30%
Colon Carcinoma
12%
Colorectal Carcinoma
27%
Cyclooxygenase 2
16%
Cytokine
11%
Cytotoxicity
30%
Diabetes Mellitus
9%
Diseases
39%
Doxorubicin
6%
Drug Resistance
12%
Enzymes
7%
Epidermal Growth Factor Receptor
24%
Flavonoid
7%
Gelatinase B
7%
Glioblastoma
14%
Glioma
7%
Glucose
9%
Hemodialysis
7%
Histone Deacetylase
8%
Histone Deacetylase 6
7%
Histone Deacetylase Inhibitor
12%
Hypertension
10%
IC50
23%
Inducible Nitric Oxide Synthase
8%
Infection
6%
Inflammation
25%
Integrin
12%
Leukemia
7%
Lipid
10%
Lipopolysaccharide
15%
Liver Cell Carcinoma
27%
Lung Adenocarcinoma
9%
Lung Cancer
28%
Malignant Neoplasm
100%
Messenger RNA
18%
microRNA
11%
Mitogen Activated Protein Kinase
20%
Mitogen Activated Protein Kinase 3
9%
Mitogen Activated Protein Kinase P38
7%
Mouse Model
9%
Mouth Cancer
8%
Nanoparticle
13%
Natural Product
6%
Neoplasm
49%
Neuroprotective Agent
7%
Nitric Oxide
11%
Non Small Cell Lung Cancer
19%
Nuclear Factor
16%
Observational Study
7%
Pancreas Cancer
9%
Parkinson's Disease
9%
Peptide
11%
Pharmacokinetics
8%
Phosphotransferase
20%
Prevalence
8%
Prostate Cancer
26%
Protein Kinase B
32%
Protein Kinase C
10%
Protein P53
13%
Randomized Controlled Trial
8%
Rat
46%
Reactive Oxygen Metabolite
21%
Receptor
10%
Side Effect
7%
Small Interfering RNA
8%
Sorafenib
7%
Thrombin
10%
Thyroid Hormone
7%
Triple Negative Breast Cancer
7%
Tubulin
11%
Tumor Growth
19%
Tumor Necrosis Factor
10%
Western Blot
17%
Biochemistry, Genetics and Molecular Biology
Allele
10%
Androgen Receptor
8%
Angiogenesis
8%
Anticancer
13%
Antineoplastic Activity
7%
Arginine
6%
Autophagy
20%
Binding Affinity
6%
Binding Site
6%
Bioinformatics
15%
Blood Plasma
10%
Cadherin
6%
Cancer Cell
95%
Cancer Growth Factor
8%
Cancer Stem Cell
11%
Carcinogenesis
37%
Catenin
13%
Cell Cycle
10%
Cell Death
13%
Cell Growth
10%
Cell Invasion
8%
Cell Migration
18%
Cell Proliferation
21%
Cisplatin
8%
Cohort Study
6%
Colon
13%
Cyclooxygenase
6%
Cytotoxicity
8%
Deficiency
8%
down Regulation
15%
Drug Resistance
16%
Enzyme
11%
Epidermal Growth Factor
7%
Epidermal Growth Factor Receptor
25%
Estrogen Receptor
8%
Expression Level
13%
Extracellular Signal-Regulated Kinases
6%
Fibrinogen
6%
Fibroblast
14%
Gelatinase B
6%
Gene Expression
36%
Gene Expression Profiling
6%
Gene Polymorphism
7%
Gene Signature
7%
Genetic Divergence
11%
Genetic Polymorphism
9%
Genetics
11%
Genome-Wide Association Study
8%
Genomics
14%
Genotyping
12%
Histone Deacetylase
11%
Homeostasis
7%
Integrin
16%
Interleukin 8
6%
Isoform
6%
Kinase
19%
Macrophage
9%
Mesenchymal-Epithelial Transition
17%
Messenger RNA
26%
Metabolic Pathway
8%
Methylation
9%
MicroRNA
28%
Mitochondrion
7%
Mitogen-Activated Protein Kinase
9%
MMP9
6%
Molecular Mechanism
10%
Mouse Model
8%
N-Terminus
6%
Overall Survival
11%
Oxidative Stress
7%
P53
14%
Peptide
11%
phosphorylation
23%
Phosphotransferase
19%
Platelet
11%
Programmed Cell Death
39%
Promoter Region
20%
Protein Expression
15%
Protein Kinase B
21%
Proteomics
8%
Rat
9%
Ribonucleotide Reductase
6%
RNA
6%
Signal Transduction
28%
Single-Nucleotide Polymorphism
15%
Small Interfering RNA
10%
Small Molecule
8%
Staining
7%
STAT3
8%
Stem Cell
19%
Synapsin I
9%
Thrombin
6%
Thyroid Hormone
9%
Transcription
11%
Transcription Factors
8%
Tumor Progression
18%
Tumor Suppressor Protein
7%
Upregulation
18%
Western Blot
9%
Wild Type
7%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
7%
Adverse Event
5%
Age Groups
5%
Alzheimer's Disease
6%
Apoplexy
22%
Area under the Curve
7%
Artificial Intelligence
10%
Asthma
5%
Biological Marker
10%
Brain Ischemia
12%
Breast Cancer
16%
Cancer
15%
Cancer Cell
16%
Cancer Growth
5%
Carcinogenesis
8%
Cardiovascular Disease
6%
Cardiovascular System
5%
Case-Control Study
13%
Cell Proliferation
5%
Cerebral Hemorrhage
5%
Cesarean Section
5%
Chemotherapy
9%
Chronic Kidney Disease
16%
Chronic Obstructive Pulmonary Disease
7%
Cohort Analysis
27%
Colorectal Carcinoma
9%
Comorbidity
11%
Computer Assisted Tomography
5%
Convolutional Neural Network
6%
COVID-19
10%
Diabetes
14%
Diabetes Mellitus
8%
Diseases
25%
Education
5%
End Stage Renal Disease
6%
Epidermal Growth Factor Receptor
6%
Erectile Dysfunction
7%
Ganglioglioma
5%
Gene Expression
6%
Genetics
5%
Hazard Ratio
17%
Health Care Cost
7%
Hepatocellular Carcinoma
11%
Hypertension
8%
In Vitro
9%
Infection
6%
Inflammation
6%
Integrin
6%
Ischemic Heart Disease
7%
Logistic Regression Analysis
14%
Lung
10%
Lung Cancer
9%
Magnetic Resonance Imaging
10%
Malignant Neoplasm
24%
Maturity Onset Diabetes of the Young
8%
Meta-Analysis
22%
Metastatic Carcinoma
5%
Nasopharynx Carcinoma
5%
Neoplasm
21%
Non Small Cell Lung Cancer
7%
Obstructive Sleep Apnea
10%
Odds Ratio
24%
Oral
5%
Osteoporosis
5%
Overall Survival
5%
Parkinson's Disease
8%
Pneumonia
6%
Prediction Model
9%
Prevalence
10%
Programmed Cell Death
9%
Proportional Hazards Model
9%
Prostate Cancer
9%
Quality of Life
5%
Radiation Therapy
13%
Randomized Controlled Trial
7%
Rectum Cancer
6%
Recurrent Disease
5%
Retrospective Cohort Study
8%
Schizophrenia
6%
Signal Transduction
9%
Survival Rate
6%
Systematic Review
13%
Thyroid Hormone
5%
Tumor
5%
Upregulation
5%